This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignees: University of Hawai'i, Institute for Cancer Research, New York University. Active years: 2016-2019.
Company Filing History:
3 out of 267 
1 out of 69 
1 out of 1,726 
Years Active: 2016-2019
Title: Michele Carbone: Innovator in Cancer Research
Introduction
Michele Carbone is a prominent inventor based in Honolulu, HI (US), known for his significant contributions to cancer research. He holds 3 patents that focus on innovative methods for diagnosing and treating cancer. His work has the potential to impact the lives of many individuals predisposed to this disease.
Latest Patents
One of Carbone's latest patents is titled "Methods for diagnosing a predisposition to develop cancer." This patent provides systems, methods, and computer-readable media for diagnosing or characterizing a genetic predisposition to develop cancer. It involves sequencing or probing nucleic acids that comprise a germline nucleic acid sequence encoding the BRCA1 associated protein 1 to determine if there are alterations that may predispose a subject to develop cancer. Another significant patent is "Treatment and prevention of cancer with HMGB1 antagonists." This patent relates to methods and compositions for treating or preventing cancer, particularly malignant mesothelioma, using antagonists of high-mobility group box 1 (HMGB1).
Career Highlights
Michele Carbone has worked with esteemed institutions such as the University of Hawai'i and New York University. His research has garnered attention for its innovative approach to understanding and combating cancer.
Collaborations
Carbone has collaborated with notable colleagues, including Haining Yang and Joseph R Testa, contributing to a rich environment of research and innovation.
Conclusion
Michele Carbone's work exemplifies the intersection of innovation and healthcare, particularly in the field of cancer research. His patents reflect a commitment to improving diagnostic and treatment methods for cancer, showcasing the importance of scientific advancement in addressing critical health challenges.